Work

A phase 1 adoptive cell therapy using drug-enhanced, tumor-infiltrating lymphocytes, DeTIL-0255, in adults with advanced malignancies.

Year: 2022

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2022.40.16_suppl.tps5602

Authors: Eugenia Girda, Emese Zsiros, John Nakayama, Sarah Whelan, Srinand Nandakumar, Seema Rogers, Beverly Benson, Frank G. Basile, Michael T. Lotze, Robert James Brown, Robert Michael Wenham

Institutions: Rutgers, The State University of New Jersey, Rutgers Cancer Institute, Roswell Park Comprehensive Cancer Center, Allegheny Health Network, Nurix (United States), Children's Hospital of Los Angeles, Moffitt Cancer Center

Language: English

Topic: CAR-T cell therapy research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4281658831

Cites:

Cited by: 3

Related to: 10